 TEL AVIV, Israel, April 19, 2021 GLOBE NEWSWIRE -- InspireMD, Inc. NYSE American: NSPR, NSPR.WS, NSPR.WSB, developer of the CGuardTM Embolic Prevention System EPS for the prevention of stroke caused by the treatment of Carotid Artery Disease CAD, today provided an update of recent corporate developments. 